Skip to main content
. 2009 Feb 26;179(11):1048–1054. doi: 10.1164/rccm.200811-1678OC

TABLE 1.

CYTOKINE mRNA LEVELS IN LUNGS OF MONOCROTALINE-TREATED AND MONOCROTALINE+XNT–TREATED RATS

Cytokine Control MCT MCT+XNT
TGF-β 1.23 ± 0.49 (4) 33.73 ± 2.96* (3) 6.18 ± 1.68# (4)
TNF-α 0.91 ± 0.16 (7) 11.46 ± 1.70* (7) 2.23 ± 0.34# (9)
IL-6 1.26 ± 0.25 (6) 55.56 ± 10.25* (6) 8.88 ± 1.59# (6)
IL-1 1.01 ± 0.01 (6) 6.76 ± 1.6* (6) 2.45 ± 0.38# (6)
NF-κB-50 0.90 ± 0.15 (8) 45.72 ± 11.9* (6) 3.01 ± 0.95# (7)
NF-κB-65 1.05 ± 0.17 (8) 4.72 ± 0.51* (8) 2.10 ± 0.35# (10)
MCP-1 1.26 ± 0.44 (6) 32.08 ± 2.63* (6) 4.22 ± 0.73# (6)
IL-10 1.42 ± 0.21 (8) 0.29 ± 0.06* (8) 3.34 ± 05.86# (10)

Definition of abbreviations: NF-κB = nuclear factor-κB; MCP = monocyte chemoattractant protein; MCT = monocrotaline; TGF = transforming growth factor; TNF = tumor necrosis factor; XNT = 1-[(2-dimethylamino) ethylamino]-4-(hydroxymethyl)-7-[(4-methylphenyl) sulfonyl oxy]-9H-xanthene-9-one.

Total RNAs from control, MCT- and MCT+XNT–treated rats were isolated and subjected to quantitation by real-time reverse transcription–polymerase chain reaction for cytokines as described. Data are expressed as mean ± SEM. Numbers in the parentheses are the number of experiments. *P < 0.05 vs. control rats, #P < 0.05 versus MCT-treated rats (one-way analysis of variance followed by the Tukey test).